Caraco Pharmaceutical Laboratories, Ltd. - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for Caraco Pharmaceutical Laboratories, Ltd.. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

Caraco Pharmaceutical Laboratories, Ltd.. The Company's principal activity is the developing, manufacturing and marketing generic and private-label pharmaceuticals. A generic drug is a pharmaceutical product, which is the chemical and therapeutic equivalent of a brand name drug as to which the patent and/or market exclusivity has expired. The Company's present product portfolio consists of 52 prescription products in 114 strengths in various package sizes. The products relate to a variety of therapeutic segments including the central nervous system, cardiology, pain management and diabetes. The customers include wholesalers, buying groups, managed care organizations, chain retail pharmacies, independent retail pharmacies and hospitals. The Company operates throughout the United States.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report